A.OchoaR
The absence of a plausible interaction mechanism no CYP450 involvement, no blood-sugar effects, and poor oral bioavailability means the theoretical risk is low
MT-2's diverse effects are due to its non-selective binding to multiple melanocortin receptor subtypes
A physician who tells you BPC-157 is FDA-approved for tendinopathy is wrong
Databases searched (and their content coverage dates) were Ovid MEDLINE(R) (1946+ including epub ahead of print, in-process, and other nonindexed citations), Ovid Embase (1974+), Ovid APA PsycInfo (1967+), Ovid Cochrane Central Register of Controlled Trials (1991+), Ovid Cochrane Database of Systematic Reviews (2005+), Web of Science Core Collection via Clarivate Analytics (1975+), and Scopus via Elsevier (1974+)
This equalizes the vacuum and gives you control over the flow rate